InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Runge Marschall S, Director. Insider active across 1 company, notably ELI LILLY & Co. Cumulatively, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €44k. History available since 15 November 2021. The latest transaction was disclosed on 1 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
202 shares@ US$246.780.0000% mcap12.7% of flowCommon StockSEC:0000059478-22-000092:0
Ideal exit: 26 Nov 2022 (T+270)
677 shares@ US$258.430.0000% mcap43.7% of flowCommon StockSEC:0000059478-21-000222:0
677 shares@ US$258.430.0000% mcap100.0% of flowCommon StockSEC:0000059478-21-000222
3 of 3 declarations
About Runge Marschall S
Marschall S. Runge is a Board Member of Eli Lilly & Co. He brings his expertise to the board, contributing to strategic decision-making for the company. His experience in the pharmaceutical sector is valuable for guiding management.
